CRISPR Therapeutics AG (CRSP) Revenue Growth (1y) (2017 - 2026)
CRISPR Therapeutics AG (CRSP) Revenue Growth (1y) (2017 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Revenue Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
37.90% |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
64.24% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
7.82% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
CRISPR Therapeutics AG |
5.21 Bn |
2.76 Bn |
- |
68.55% |
| Date | Value |
|---|
| Mar 31, 2026 |
68.55% |
| Dec 31, 2025 |
-97.58% |
| Sep 30, 2025 |
47.67% |
| Jun 30, 2025 |
72.53% |
| Mar 31, 2025 |
71.63% |
| Dec 31, 2024 |
-82.26% |
| Jun 30, 2024 |
-99.26% |
| Mar 31, 2024 |
-99.50% |
| Dec 31, 2023 |
3,353,333.33% |
| Jun 30, 2023 |
44,203.80% |
| Mar 31, 2023 |
10,538.30% |
| Dec 31, 2022 |
-99.95% |
| Sep 30, 2022 |
-88.59% |
| Jun 30, 2022 |
-99.98% |
| Mar 31, 2022 |
74.40% |
| Dec 31, 2021 |
3,386.22% |
| Sep 30, 2021 |
456.76% |
| Jun 30, 2021 |
2,046,947.73% |
| Mar 31, 2021 |
243.31% |
| Dec 31, 2020 |
-99.52% |
